Abstract:Backgrounds: Epidermal growth factor (EGF) is a 53 amino acid polypeptide and its receptor EGFR is an established therapeutic target for anti-tumor therapy. Two major categories of EGFR-targeted drugs include monoclonal antibodies (mAbs) and small molecular tyrosine kinase inhibitors (TKIs). However, drug resistance occurs in a significant proportion of patients due to EGFR mutations. Since EGFR can maintain activation while abrogating the activity of mAbs or TKIs, or bypass signaling functions while successfully circumventing the EGF-EGFR switch, developing new mechanism-based inhibitors is necessary. Methods: In this study, based on the principle of tumor immunotherapy, a recombinant protein pLLO-hEGF was constructed. The N-terminal portion contains three immunodominant epitopes from listeriolysin O (LLO) and the C-terminal includes EGF. To use EGF as a target vector to recognize EGFR-expressing cancer cells, immunodominant epitopes could enhance immunogenicity of tumor cells for immune cell activation and attack. Results: Recombinant protein pLLO-hEGF was successfully expressed and showed strong affinity to cancer cells. Also, pLLO-hEGF could significantly stimulate human lymphocyte proliferation and the lymphocytes demonstrated enhanced killing potency in EGFR-expressing cancer cells in vitro and in vivo. Conclusion: This study can provide novel strategies and directions in tumor biotherapy.

[Cloning of Transmembrane Domain Sequence of EGFR Gene]

Molecular Cloning and Sequence Analysis of Cdna Encoding Human EGF Receptor Extracellular Domain

Clone of cDNA encoding PEP-3 epitope of epidermal growth factor receptor type Ⅲ mutant

Construction of Expression Vector of Superantigen Staphylococcal Enterotoxin A Gene

Expression of Intracellular Domain of Epidermal Growth Factor Receptor and Generation of Its Monoclonal Antibody

Molecular Cloning of Fuse Gene to Coactivate TAG-72 Specific T Lymphocytes

[Expression, Purification and Refolding of Extracellular Domain of Mouse Epidermal Growth Factor Receptor].

Cloning and Expression of a Fused Gene Encoding TNFRI Death Domain and Chloramphenicol Acetyltransferase.

Cloning and Prokaryotic Expression of HER-2/neu Extracellular Domain

The cloning of thyroglobulin epitopes gene and construction of its prokaryotic expression vector

Cloning and Expression of the Extracellular Domain of Human CD40 Antigen Gene

Prokaryotic Expression of Extracellular Domain of Human EGFR and It's Immunogenity

The Construction of Anti-EGFR Single Chain Variable Fragment Fused with Gelonin Toxin Prokaryotic Expressing Plasmid and the Study of Its Anti-tumor Effects

Clone and expression of human transferrin receptor gene:a marker gene for magnetic resonance imaging

Cloning and Expression of Gene Encoding PH Domains of Signaling Molecules GRF

Construction and Identification of Pwpxl-Egfp-ires-htfr Lentivirus Vector

Construction of recombinant human endothelin1 tandem and expression in COS-7 cells

Constructing and identifying the prokaryotic expressive vector of amino domain on the extracellular domain of human thyrotropin receptor cDNA

Cloning and construction of expression vector of human proton-sensing receptor TDAG8 and its transient transfection into 293T cells

Cloning of Human Germinal Center Kinase Gene and Construction of Its Transgenic Cells

Cloning and expression of a novel target fusion protein and its application in anti-tumor therapy